Essential Thrombocythemia Complicated by Addison's Disease: A Case of Overlapping Endocrine and Hematological Disorders

IF 1.8 Q3 HEMATOLOGY
Meryem SENER , Kaan NISANOGLU , Candas MUMCU , Bengisu Ece DUMAN , Berra Nur ISCI , Emre BAL , Irem KABALCI KADIOGLU , Birol GUVENC
{"title":"Essential Thrombocythemia Complicated by Addison's Disease: A Case of Overlapping Endocrine and Hematological Disorders","authors":"Meryem SENER ,&nbsp;Kaan NISANOGLU ,&nbsp;Candas MUMCU ,&nbsp;Bengisu Ece DUMAN ,&nbsp;Berra Nur ISCI ,&nbsp;Emre BAL ,&nbsp;Irem KABALCI KADIOGLU ,&nbsp;Birol GUVENC","doi":"10.1016/j.htct.2024.04.018","DOIUrl":null,"url":null,"abstract":"<div><p>This case report delves into the intricacies of managing a patient diagnosed with both essential thrombocythemia and Addison's disease, illustrating the challenges and importance of an integrated approach to complex, coexisting conditions. A 47-year-old woman presented with enduring symptoms of fatigue, skin darkening, and appetite loss, which progressively led to substantial weight loss. Initially treated for essential thrombocythemia, a common yet serious myeloproliferative disorder, her condition did not fully improve with standard therapy, including hydroxyurea. Further evaluation was prompted by her deteriorating clinical status, characterized by severe hypotension and exacerbated systemic symptoms, leading to the diagnosis of primary adrenal insufficiency or Addison's disease. The confirmation of Addison's disease, alongside essential thrombocythemia, necessitated a tailored therapeutic strategy that addressed both endocrine and hematological aspects. With the initiation of appropriate therapy targeting Addison's disease, alongside ongoing management of essential thrombocythemia, the patient experienced a significant alleviation of symptoms and stabilization of her condition. This case underscores the necessity for vigilance and comprehensive evaluation in patients with non-specific systemic symptoms, highlighting the potential for concurrent, serious medical diagnoses.</p></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531137924001007/pdfft?md5=a0bc760a8477717ab9ba28149b7be0b6&pid=1-s2.0-S2531137924001007-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137924001007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This case report delves into the intricacies of managing a patient diagnosed with both essential thrombocythemia and Addison's disease, illustrating the challenges and importance of an integrated approach to complex, coexisting conditions. A 47-year-old woman presented with enduring symptoms of fatigue, skin darkening, and appetite loss, which progressively led to substantial weight loss. Initially treated for essential thrombocythemia, a common yet serious myeloproliferative disorder, her condition did not fully improve with standard therapy, including hydroxyurea. Further evaluation was prompted by her deteriorating clinical status, characterized by severe hypotension and exacerbated systemic symptoms, leading to the diagnosis of primary adrenal insufficiency or Addison's disease. The confirmation of Addison's disease, alongside essential thrombocythemia, necessitated a tailored therapeutic strategy that addressed both endocrine and hematological aspects. With the initiation of appropriate therapy targeting Addison's disease, alongside ongoing management of essential thrombocythemia, the patient experienced a significant alleviation of symptoms and stabilization of her condition. This case underscores the necessity for vigilance and comprehensive evaluation in patients with non-specific systemic symptoms, highlighting the potential for concurrent, serious medical diagnoses.

由阿狄森氏病并发的原发性血小板增多症:一例内分泌与血液病重叠的病例
本病例报告深入探讨了管理一名同时被诊断患有原发性血小板增多症和阿狄森氏病的患者的复杂性,说明了综合治疗复杂并存疾病的挑战和重要性。一名 47 岁的妇女出现了疲劳、皮肤变黑和食欲不振等持久症状,并逐渐导致体重大幅下降。最初,她被诊断为原发性血小板增多症(一种常见但严重的骨髓增生性疾病),但经过包括羟基脲在内的标准治疗后,病情并未完全好转。她的临床状况不断恶化,表现为严重的低血压和全身症状加重,因此被诊断为原发性肾上腺功能不全或阿狄森氏病。在确诊阿狄森氏病的同时,还确诊了原发性血小板增多症,因此有必要从内分泌和血液学两方面入手,采取有针对性的治疗策略。随着针对阿狄森病的适当治疗的开始,以及对血小板增多症的持续治疗,患者的症状明显缓解,病情也趋于稳定。本病例强调了对有非特异性全身症状的患者保持警惕和进行全面评估的必要性,并突出了并发严重疾病诊断的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
4.80%
发文量
1419
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信